Literature DB >> 29894562

Identifying disease-associated copy number variations by a doubly penalized regression model.

Yichen Cheng1, James Y Dai2, Xiaoyu Wang2, Charles Kooperberg2.   

Abstract

Copy number variation (CNV) of DNA plays an important role in the development of many diseases. However, due to the irregularity and sparsity of the CNVs, studying the association between CNVs and a disease outcome or a trait can be challenging. Up to now, not many methods have been proposed in the literature for this problem. Most of the current researchers reply on an ad hoc two-stage procedure by first identifying CNVs in each individual genome and then performing an association test using these identified CNVs. This potentially leads to information loss and as a result a lower power to identify disease associated CNVs. In this article, we describe a new method that combines the two steps into a single coherent model to identify the common CNV across patients that are associated with certain diseases. We use a double penalty model to capture CNVs' association with both the intensities and the disease trait. We validate its performance in simulated datasets and a data example on platinum resistance and CNV in ovarian cancer genome.
© 2018, The International Biometric Society.

Entities:  

Keywords:  Association study; Copy number variation; Ovarian cancer; Penalized regression model

Mesh:

Substances:

Year:  2018        PMID: 29894562      PMCID: PMC6663092          DOI: 10.1111/biom.12920

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  35 in total

1.  Circular binary segmentation for the analysis of array-based DNA copy number data.

Authors:  Adam B Olshen; E S Venkatraman; Robert Lucito; Michael Wigler
Journal:  Biostatistics       Date:  2004-10       Impact factor: 5.899

2.  Spatial smoothing and hot spot detection for CGH data using the fused lasso.

Authors:  Robert Tibshirani; Pei Wang
Journal:  Biostatistics       Date:  2007-05-18       Impact factor: 5.899

3.  Integrated detection and population-genetic analysis of SNPs and copy number variation.

Authors:  Steven A McCarroll; Finny G Kuruvilla; Joshua M Korn; Simon Cawley; James Nemesh; Alec Wysoker; Michael H Shapero; Paul I W de Bakker; Julian B Maller; Andrew Kirby; Amanda L Elliott; Melissa Parkin; Earl Hubbell; Teresa Webster; Rui Mei; James Veitch; Patrick J Collins; Robert Handsaker; Steve Lincoln; Marcia Nizzari; John Blume; Keith W Jones; Rich Rava; Mark J Daly; Stacey B Gabriel; David Altshuler
Journal:  Nat Genet       Date:  2008-09-07       Impact factor: 38.330

4.  PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data.

Authors:  Kai Wang; Mingyao Li; Dexter Hadley; Rui Liu; Joseph Glessner; Struan F A Grant; Hakon Hakonarson; Maja Bucan
Journal:  Genome Res       Date:  2007-10-05       Impact factor: 9.043

5.  RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer.

Authors:  P A Bignone; K Y Lee; Y Liu; G Emilion; J Finch; A E R Soosay; F M L Charnock; S Beck; I Dunham; A J Mungall; T S Ganesan
Journal:  Oncogene       Date:  2006-07-31       Impact factor: 9.867

6.  STAC: A method for testing the significance of DNA copy number aberrations across multiple array-CGH experiments.

Authors:  Sharon J Diskin; Thomas Eck; Joel Greshock; Yael P Mosse; Tara Naylor; Christian J Stoeckert; Barbara L Weber; John M Maris; Gregory R Grant
Journal:  Genome Res       Date:  2006-08-09       Impact factor: 9.043

7.  Gains of 1q21-q22 and 13q12-q14 are potential indicators for resistance to cisplatin-based chemotherapy in ovarian cancer patients.

Authors:  K Kudoh; M Takano; T Koshikawa; M Hirai; S Yoshida; Y Mano; K Yamamoto; K Ishii; T Kita; Y Kikuchi; I Nagata; M Miwa; K Uchida
Journal:  Clin Cancer Res       Date:  1999-09       Impact factor: 12.531

8.  Allele loss on chromosome 1p36 in epithelial ovarian cancers.

Authors:  A A Alvarez; A R Lambers; J M Lancaster; G L Maxwell; S Ali; C Gumbs; A Berchuck; P A Futreal
Journal:  Gynecol Oncol       Date:  2001-07       Impact factor: 5.482

9.  A candidate tumor suppressor HtrA1 is downregulated in ovarian cancer.

Authors:  Jeremy Chien; Julie Staub; Shou-Ih Hu; Michele R Erickson-Johnson; Fergus J Couch; David I Smith; Robert M Crowl; Scott H Kaufmann; Viji Shridhar
Journal:  Oncogene       Date:  2004-02-26       Impact factor: 9.867

10.  A robust statistical method for case-control association testing with copy number variation.

Authors:  Chris Barnes; Vincent Plagnol; Tomas Fitzgerald; Richard Redon; Jonathan Marchini; David Clayton; Matthew E Hurles
Journal:  Nat Genet       Date:  2008-09-07       Impact factor: 38.330

View more
  3 in total

1.  Tissue-specific identification of multi-omics features for pan-cancer drug response prediction.

Authors:  Zhi Zhao; Shixiong Wang; Manuela Zucknick; Tero Aittokallio
Journal:  iScience       Date:  2022-07-19

2.  Supervised t-distributed stochastic neighbor embedding for data visualization and classification.

Authors:  Yichen Cheng; Xinlei Wang; Yusen Xia
Journal:  INFORMS J Comput       Date:  2020-09-10       Impact factor: 2.276

3.  A Novel Computational Framework to Predict Disease-Related Copy Number Variations by Integrating Multiple Data Sources.

Authors:  Lin Yuan; Tao Sun; Jing Zhao; Zhen Shen
Journal:  Front Genet       Date:  2021-06-29       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.